Similar articles

• Myogenic hyperuricemia: a comparative study between type V and type VII glycogenosis.

  Hara N, Mineo I, Kono N, Kiyokawa H, Kawachi M, Yamada Y, Nakajima H, Shimizu T, Kuwajima M, Wang YL, et al. Hara N, et al. Adv Exp Med Biol. 1989;253A:381-6. doi: 10.1007/978-1-4684-5673-8_62. Adv Exp Med Biol. 1989. PMID: 2624217 No abstract available.
• [Glycogenosis (molecular mechanism of muscle glycogenosis)].

  Tarui S, Mineo I, Nakajima H, Kono N. Tarui S, et al. Tanpakushitsu Kakusan Koso. 1988 Apr;33(5):637-42. Tanpakushitsu Kakusan Koso. 1988. PMID: 3270875 Japanese. No abstract available.
• Myogenic hyperuricemia. A common pathophysiologic feature of glycogenosis types III, V, and VII.

  Mineo I, Kono N, Hara N, Shimizu T, Yamada Y, Kawachi M, Kiyokawa H, Wang YL, Tarui S. Mineo I, et al. N Engl J Med. 1987 Jul 9;317(2):75-80. doi: 10.1056/NEJM198707093170203. N Engl J Med. 1987. PMID: 3473284
• [Myogenic hyperuricemia].

  Yamasaki T, Hamaguchi T, Nakajima H, Matsuzawa Y. Yamasaki T, et al. Nihon Rinsho. 1996 Dec;54(12):3343-8. Nihon Rinsho. 1996. PMID: 8976117 Review. Japanese.
• [Secondary hyperuricemia in glycogen storage disease types I, III, V and VII].

  Yamasaki T, Mineo I. Yamasaki T, et al. Nihon Rinsho. 2003 Jan;61 Suppl 1:307-12. Nihon Rinsho. 2003. PMID: 12629737 Review. Japanese. No abstract available.